(Q83823483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Anne M McDonnell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kristi L Lenz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Debra A Frei-Lahr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

John Hayslip

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Philip D Hall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

806-812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

Treatment of impending tumor lysis with single-dose rasburicase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

Use of single-dose rasburicase in an obese female

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.806

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.6.806

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716134%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference